Literature DB >> 2732023

Effect of topical timolol maleate on the ophthalmic artery blood pressure.

J E Grunwald1, C Furubayashi.   

Abstract

The effects of topical timolol maleate 0.5% on the ophthalmic artery diastolic (OABPd), systolic (OABPs) and mean blood pressure (OABPm) were investigated in 19 healthy subjects using compression ophthalmodynamometry. In a randomized, double-blind study, one eye of each subject received one drop of timolol maleate 0.5% and the fellow eye received a drop of placebo. Measurements of OABPd and OABPs were performed just prior to instillation of the drops, and then 2 hr later. OABPm was calculated as OABPm = OABPd + 1/3 (OABPs - OABPd). No significant changes in OABPd, OABPs or OABPm were observed following the drops in the timolol-treated eyes or in the placebo-treated eyes. A significant difference (P = 0.0198) was found, however, when the changes in OABPm occurring in the timolol-treated eyes were compared with the changes occurring in the placebo-treated eyes, suggesting that the drug may have an effect upon ophthalmic artery pressure and retinal artery pressure that is expressed differently in each eye.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732023

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

Review 1.  Ocular blood flow measurement.

Authors:  T H Williamson; A Harris
Journal:  Br J Ophthalmol       Date:  1994-12       Impact factor: 4.638

2.  Acute effect of metipranolol on the retinal circulation.

Authors:  S Wolf; E Werner; K Schulte; M Reim
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

3.  Relation between pressure determined by ophthalmodynamometry and aortic pressure in the dog.

Authors:  W H Morgan; D Y Yu; V A Alder; S J Cringle; I J Constable
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

4.  Postural studies in pulsatile ocular blood flow: II. Chronic open angle glaucoma.

Authors:  D R Trew; S E Smith
Journal:  Br J Ophthalmol       Date:  1991-02       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.